Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 34 entries
Sorted by: Best Match Show Resources per page
Poly[[pentaaquasulfato-micro4-(R,R)-tartrato-dicadmium(II)] trihydrate].

Acta crystallographica. Section C, Crystal structure communications

Drzewiecka A, Stepniak K, Barcicka A, Koziol AE.
PMID: 17675679
Acta Crystallogr C. 2007 Aug;63:m346-8. doi: 10.1107/S0108270107027862. Epub 2007 Jul 05.

The asymmetric unit in the title compound, {[Cd(2)(C(4)H(4)O(6))(SO(4))(H(2)O)(5)].3H(2)O}(n), is composed of two cadmium cations, one (R,R)-tartrate and one sulfate anion, five aqua ligands and three solvent water molecules. One of the cadmium ions is coordinated in an octahedral environment,...

Cite
Drzewiecka A, Stepniak K, Barcicka A, et al. Poly[[pentaaquasulfato-micro4-(R,R)-tartrato-dicadmium(II)] trihydrate]. Acta Crystallogr C. 2007;63:m346-8doi: 10.1107/S0108270107027862.
Drzewiecka, A., Stepniak, K., Barcicka, A., & Koziol, A. E. (2007). Poly[[pentaaquasulfato-micro4-(R,R)-tartrato-dicadmium(II)] trihydrate]. Acta crystallographica. Section C, Crystal structure communications, 63m346-8. https://doi.org/10.1107/S0108270107027862
Drzewiecka, Aleksandra, et al. "Poly[[pentaaquasulfato-micro4-(R,R)-tartrato-dicadmium(II)] trihydrate]." Acta crystallographica. Section C, Crystal structure communications vol. 63 (2007): m346-8. doi: https://doi.org/10.1107/S0108270107027862
Drzewiecka A, Stepniak K, Barcicka A, Koziol AE. Poly[[pentaaquasulfato-micro4-(R,R)-tartrato-dicadmium(II)] trihydrate]. Acta Crystallogr C. 2007 Aug;63:m346-8. doi: 10.1107/S0108270107027862. Epub 2007 Jul 05. PMID: 17675679.
Copy Download .nbib Format: NLM
Cardiac force and muscle shortening in regional ischemia: asynchronization and possible uncoupling.

Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference

Li JK, Zhu Y, Guan X, Drzewiecki G, Kedem J.
PMID: 17281555
Conf Proc IEEE Eng Med Biol Soc. 2005;2005:5716-8. doi: 10.1109/IEMBS.2005.1615785.

Acute myocardial ischemia affects both cardiac muscle force development and shortening in the affected regions. The exact mechanisms are unclear. We investigated myocardial function during ischemia and reperfusion both experimentally and with a muscle fiber model. The model was...

Cite
Li JK, Zhu Y, Guan X, et al. Cardiac force and muscle shortening in regional ischemia: asynchronization and possible uncoupling. Conf Proc IEEE Eng Med Biol Soc. 2005;2005:5716-8doi: 10.1109/IEMBS.2005.1615785.
Li, J. K., Zhu, Y., Guan, X., Drzewiecki, G., & Kedem, J. (2005). Cardiac force and muscle shortening in regional ischemia: asynchronization and possible uncoupling. Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference, 20055716-8. https://doi.org/10.1109/IEMBS.2005.1615785
Li, John K-J, et al. "Cardiac force and muscle shortening in regional ischemia: asynchronization and possible uncoupling." Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference vol. 2005 (2005): 5716-8. doi: https://doi.org/10.1109/IEMBS.2005.1615785
Li JK, Zhu Y, Guan X, Drzewiecki G, Kedem J. Cardiac force and muscle shortening in regional ischemia: asynchronization and possible uncoupling. Conf Proc IEEE Eng Med Biol Soc. 2005;2005:5716-8. doi: 10.1109/IEMBS.2005.1615785. PMID: 17281555.
Copy Download .nbib Format: NLM
Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy.

Gynecology & obstetrics (Sunnyvale, Calif.)

Szajnik M, Derbis M, Lach M, Patalas P, Michalak M, Drzewiecka H, Szpurek D, Nowakowski A, Spaczynski M, Baranowski W, Whiteside TL.
PMID: 24466501
Gynecol Obstet (Sunnyvale). 2013 Apr 29;3. doi: 10.4172/2161-0932.S4-003.

BACKGROUND: In patients with Ovarian Cancer (OvCa) exosomes released by tumor cells are present in the plasma and could be involved in tumor progression. This study examines the association between the exosome presence/protein content in plasma of OvCa patients...

Cite
Szajnik M, Derbis M, Lach M, et al. Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy. Gynecol Obstet (Sunnyvale). 2013;3doi: 10.4172/2161-0932.S4-003.
Szajnik, M., Derbis, M., Lach, M., Patalas, P., Michalak, M., Drzewiecka, H., Szpurek, D., Nowakowski, A., Spaczynski, M., Baranowski, W., & Whiteside, T. L. (2013). Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy. Gynecology & obstetrics (Sunnyvale, Calif.), 3. https://doi.org/10.4172/2161-0932.S4-003
Szajnik, Marta, et al. "Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy." Gynecology & obstetrics (Sunnyvale, Calif.) vol. (2013): 3. doi: https://doi.org/10.4172/2161-0932.S4-003
Szajnik M, Derbis M, Lach M, Patalas P, Michalak M, Drzewiecka H, Szpurek D, Nowakowski A, Spaczynski M, Baranowski W, Whiteside TL. Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy. Gynecol Obstet (Sunnyvale). 2013 Apr 29;3. doi: 10.4172/2161-0932.S4-003. PMID: 24466501; PMCID: PMC3899646.
Copy Download .nbib Format: NLM
The problem of medical dispatchers' responsibility functioning in the emergency medical services system.

Archiwum medycyny sadowej i kryminologii

Chowaniec C, Lada M, Wajda-Drzewiecka K, Skowronek R, Drzewiecki A.
PMID: 25184425
Arch Med Sadowej Kryminol. 2014 Jan-Mar;64(1):34-43. doi: 10.5114/amsik.2014.44588.

AIM OF THE STUDY: Deaths due to inappropriate functioning of the emergency medical services system, as recently described by Polish mass media, has drawn the attention of society to the activities of medical dispatchers. Legal regulations impose obligations on...

Cite
Chowaniec C, Lada M, Wajda-Drzewiecka K, et al. The problem of medical dispatchers' responsibility functioning in the emergency medical services system. Arch Med Sadowej Kryminol. 2014;64(1):34-43doi: 10.5114/amsik.2014.44588.
Chowaniec, C., Lada, M., Wajda-Drzewiecka, K., Skowronek, R., & Drzewiecki, A. (2014). The problem of medical dispatchers' responsibility functioning in the emergency medical services system. Archiwum medycyny sadowej i kryminologii, 64(1), 34-43. https://doi.org/10.5114/amsik.2014.44588
Chowaniec, C, et al. "The problem of medical dispatchers' responsibility functioning in the emergency medical services system." Archiwum medycyny sadowej i kryminologii vol. 64,1 (2014): 34-43. doi: https://doi.org/10.5114/amsik.2014.44588
Chowaniec C, Lada M, Wajda-Drzewiecka K, Skowronek R, Drzewiecki A. The problem of medical dispatchers' responsibility functioning in the emergency medical services system. Arch Med Sadowej Kryminol. 2014 Jan-Mar;64(1):34-43. doi: 10.5114/amsik.2014.44588. PMID: 25184425.
Copy Download .nbib Format: NLM
Circulating vascular endothelial growth factor receptor 2 levels and their association with lipid abnormalities in patients on hemodialysis.

Biomedical reports

Niepolski L, Drzewiecka H, Warchoł W.
PMID: 33692900
Biomed Rep. 2021 Apr;14(4):37. doi: 10.3892/br.2021.1413. Epub 2021 Feb 26.

The aim of the present study was to examine the association between the levels of circulating vascular endothelial growth factor receptor (VEGFR)2 levels, serum lipid composition and plasma receptor for advanced glycation end-products (RAGE) expression in patients undergoing hemodialysis...

Cite
Niepolski L, Drzewiecka H, Warchoł W. Circulating vascular endothelial growth factor receptor 2 levels and their association with lipid abnormalities in patients on hemodialysis. Biomed Rep. 2021;14(4):37doi: 10.3892/br.2021.1413.
Niepolski, L., Drzewiecka, H., & Warchoł, W. (2021). Circulating vascular endothelial growth factor receptor 2 levels and their association with lipid abnormalities in patients on hemodialysis. Biomedical reports, 14(4), 37. https://doi.org/10.3892/br.2021.1413
Niepolski, Leszek, et al. "Circulating vascular endothelial growth factor receptor 2 levels and their association with lipid abnormalities in patients on hemodialysis." Biomedical reports vol. 14,4 (2021): 37. doi: https://doi.org/10.3892/br.2021.1413
Niepolski L, Drzewiecka H, Warchoł W. Circulating vascular endothelial growth factor receptor 2 levels and their association with lipid abnormalities in patients on hemodialysis. Biomed Rep. 2021 Apr;14(4):37. doi: 10.3892/br.2021.1413. Epub 2021 Feb 26. PMID: 33692900; PMCID: PMC7938296.
Copy Download .nbib Format: NLM
The Possibility of Using .

Plants (Basel, Switzerland)

Drzewiecka K, Gąsecka M, Magdziak Z, Budzyńska S, Szostek M, Niedzielski P, Budka A, Roszyk E, Doczekalska B, Górska M, Mleczek M.
PMID: 34685857
Plants (Basel). 2021 Sep 29;10(10). doi: 10.3390/plants10102049.

The potential of the

Cite
Drzewiecka K, Gąsecka M, Magdziak Z, et al. The Possibility of Using . Plants (Basel). 2021;10(10)doi: 10.3390/plants10102049.
Drzewiecka, K., Gąsecka, M., Magdziak, Z., Budzyńska, S., Szostek, M., Niedzielski, P., Budka, A., Roszyk, E., Doczekalska, B., Górska, M., & Mleczek, M. (2021). The Possibility of Using . Plants (Basel, Switzerland), 10(10), . https://doi.org/10.3390/plants10102049
Drzewiecka, Kinga, et al. "The Possibility of Using ." Plants (Basel, Switzerland) vol. 10,10 (2021). doi: https://doi.org/10.3390/plants10102049
Drzewiecka K, Gąsecka M, Magdziak Z, Budzyńska S, Szostek M, Niedzielski P, Budka A, Roszyk E, Doczekalska B, Górska M, Mleczek M. The Possibility of Using . Plants (Basel). 2021 Sep 29;10(10). doi: 10.3390/plants10102049. PMID: 34685857; PMCID: PMC8541643.
Copy Download .nbib Format: NLM
17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer.

ACS medicinal chemistry letters

Gargano EM, Mohamed A, Abdelsamie AS, Mangiatordi GF, Drzewiecka H, Jagodziński PP, Mazzini A, van Koppen CJ, Laschke MW, Nicolotti O, Carotti A, Marchais-Oberwinkler S, Hartmann RW, Frotscher M.
PMID: 34917255
ACS Med Chem Lett. 2021 Nov 18;12(12):1920-1924. doi: 10.1021/acsmedchemlett.1c00462. eCollection 2021 Dec 09.

In the face of the clinical challenge posed by non-small cell lung cancer (NSCLC), the present need for new therapeutic approaches is genuine. Up to now, no proof existed that 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) is a viable target...

Cite
Gargano EM, Mohamed A, Abdelsamie AS, et al. 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer. ACS Med Chem Lett. 2021;12(12):1920-1924doi: 10.1021/acsmedchemlett.1c00462.
Gargano, E. M., Mohamed, A., Abdelsamie, A. S., Mangiatordi, G. F., Drzewiecka, H., Jagodziński, P. P., Mazzini, A., van Koppen, C. J., Laschke, M. W., Nicolotti, O., Carotti, A., Marchais-Oberwinkler, S., Hartmann, R. W., & Frotscher, M. (2021). 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer. ACS medicinal chemistry letters, 12(12), 1920-1924. https://doi.org/10.1021/acsmedchemlett.1c00462
Gargano, Emanuele M, et al. "17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer." ACS medicinal chemistry letters vol. 12,12 (2021): 1920-1924. doi: https://doi.org/10.1021/acsmedchemlett.1c00462
Gargano EM, Mohamed A, Abdelsamie AS, Mangiatordi GF, Drzewiecka H, Jagodziński PP, Mazzini A, van Koppen CJ, Laschke MW, Nicolotti O, Carotti A, Marchais-Oberwinkler S, Hartmann RW, Frotscher M. 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer. ACS Med Chem Lett. 2021 Nov 18;12(12):1920-1924. doi: 10.1021/acsmedchemlett.1c00462. eCollection 2021 Dec 09. PMID: 34917255; PMCID: PMC8667298.
Copy Download .nbib Format: NLM
Physical Activity and DNA Methylation in Humans.

International journal of molecular sciences

Światowy WJ, Drzewiecka H, Kliber M, Sąsiadek M, Karpiński P, Pławski A, Jagodziński PP.
PMID: 34884790
Int J Mol Sci. 2021 Nov 30;22(23). doi: 10.3390/ijms222312989.

Physical activity is a strong stimulus influencing the overall physiology of the human body. Exercises lead to biochemical changes in various tissues and exert an impact on gene expression. Exercise-induced changes in gene expression may be mediated by epigenetic...

Cite
Światowy WJ, Drzewiecka H, Kliber M, et al. Physical Activity and DNA Methylation in Humans. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222312989.
Światowy, W. J., Drzewiecka, H., Kliber, M., Sąsiadek, M., Karpiński, P., Pławski, A., & Jagodziński, P. P. (2021). Physical Activity and DNA Methylation in Humans. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222312989
Światowy, Witold Józef, et al. "Physical Activity and DNA Methylation in Humans." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222312989
Światowy WJ, Drzewiecka H, Kliber M, Sąsiadek M, Karpiński P, Pławski A, Jagodziński PP. Physical Activity and DNA Methylation in Humans. Int J Mol Sci. 2021 Nov 30;22(23). doi: 10.3390/ijms222312989. PMID: 34884790; PMCID: PMC8657566.
Copy Download .nbib Format: NLM
17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer.

ACS medicinal chemistry letters

Gargano EM, Mohamed A, Abdelsamie AS, Mangiatordi GF, Drzewiecka H, Jagodziński PP, Mazzini A, van Koppen CJ, Laschke MW, Nicolotti O, Carotti A, Marchais-Oberwinkler S, Hartmann RW, Frotscher M.
PMID: 34917255
ACS Med Chem Lett. 2021 Nov 18;12(12):1920-1924. doi: 10.1021/acsmedchemlett.1c00462. eCollection 2021 Dec 09.

In the face of the clinical challenge posed by non-small cell lung cancer (NSCLC), the present need for new therapeutic approaches is genuine. Up to now, no proof existed that 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) is a viable target...

Cite
Gargano EM, Mohamed A, Abdelsamie AS, et al. 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer. ACS Med Chem Lett. 2021;12(12):1920-1924doi: 10.1021/acsmedchemlett.1c00462.
Gargano, E. M., Mohamed, A., Abdelsamie, A. S., Mangiatordi, G. F., Drzewiecka, H., Jagodziński, P. P., Mazzini, A., van Koppen, C. J., Laschke, M. W., Nicolotti, O., Carotti, A., Marchais-Oberwinkler, S., Hartmann, R. W., & Frotscher, M. (2021). 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer. ACS medicinal chemistry letters, 12(12), 1920-1924. https://doi.org/10.1021/acsmedchemlett.1c00462
Gargano, Emanuele M, et al. "17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer." ACS medicinal chemistry letters vol. 12,12 (2021): 1920-1924. doi: https://doi.org/10.1021/acsmedchemlett.1c00462
Gargano EM, Mohamed A, Abdelsamie AS, Mangiatordi GF, Drzewiecka H, Jagodziński PP, Mazzini A, van Koppen CJ, Laschke MW, Nicolotti O, Carotti A, Marchais-Oberwinkler S, Hartmann RW, Frotscher M. 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer. ACS Med Chem Lett. 2021 Nov 18;12(12):1920-1924. doi: 10.1021/acsmedchemlett.1c00462. eCollection 2021 Dec 09. PMID: 34917255; PMCID: PMC8667298.
Copy Download .nbib Format: NLM
Phenotyping of Mice with Heart Specific Overexpression of A.

Frontiers in pharmacology

Boknik P, Drzewiecki K, Eskandar J, Gergs U, Grote-Wessels S, Fabritz L, Kirchhof P, Müller FU, Stümpel F, Schmitz W, Zimmermann N, Kirchhefer U, Neumann J.
PMID: 29403384
Front Pharmacol. 2018 Jan 22;9:13. doi: 10.3389/fphar.2018.00013. eCollection 2018.

No abstract available.

Cite
Boknik P, Drzewiecki K, Eskandar J, et al. Phenotyping of Mice with Heart Specific Overexpression of A. Front Pharmacol. 2018;9:13doi: 10.3389/fphar.2018.00013.
Boknik, P., Drzewiecki, K., Eskandar, J., Gergs, U., Grote-Wessels, S., Fabritz, L., Kirchhof, P., Müller, F. U., Stümpel, F., Schmitz, W., Zimmermann, N., Kirchhefer, U., & Neumann, J. (2018). Phenotyping of Mice with Heart Specific Overexpression of A. Frontiers in pharmacology, 913. https://doi.org/10.3389/fphar.2018.00013
Boknik, Peter, et al. "Phenotyping of Mice with Heart Specific Overexpression of A." Frontiers in pharmacology vol. 9 (2018): 13. doi: https://doi.org/10.3389/fphar.2018.00013
Boknik P, Drzewiecki K, Eskandar J, Gergs U, Grote-Wessels S, Fabritz L, Kirchhof P, Müller FU, Stümpel F, Schmitz W, Zimmermann N, Kirchhefer U, Neumann J. Phenotyping of Mice with Heart Specific Overexpression of A. Front Pharmacol. 2018 Jan 22;9:13. doi: 10.3389/fphar.2018.00013. eCollection 2018. PMID: 29403384; PMCID: PMC5786519.
Copy Download .nbib Format: NLM
Differential expression of tumor necrosis factor α, interleukin 1β, nuclear factor κB in nasal mucosa among chronic rhinosinusitis patients with and without polyps.

Postepy dermatologii i alergologii

Plewka D, Grzanka A, Drzewiecka E, Plewka A, Misiołek M, Lisowska G, Rostkowska-Nadolska B, Gawlik R.
PMID: 28670247
Postepy Dermatol Alergol. 2017 Jun;34(3):199-206. doi: 10.5114/ada.2017.67842. Epub 2017 May 29.

INTRODUCTION: The pathogenesis of nasal polyps is still not fully understood.AIM: To analyze the topography and intensity of interleukin 1β (IL-1β), tumor necrosis factor α (TNF-α), cyclooxygenase 2 (COX-2), nitric oxide synthase 2 (NOS-2), and nuclear factor-κB (NF-κB) expressions...

Cite
Plewka D, Grzanka A, Drzewiecka E, et al. Differential expression of tumor necrosis factor α, interleukin 1β, nuclear factor κB in nasal mucosa among chronic rhinosinusitis patients with and without polyps. Postepy Dermatol Alergol. 2017;34(3):199-206doi: 10.5114/ada.2017.67842.
Plewka, D., Grzanka, A., Drzewiecka, E., Plewka, A., Misiołek, M., Lisowska, G., Rostkowska-Nadolska, B., & Gawlik, R. (2017). Differential expression of tumor necrosis factor α, interleukin 1β, nuclear factor κB in nasal mucosa among chronic rhinosinusitis patients with and without polyps. Postepy dermatologii i alergologii, 34(3), 199-206. https://doi.org/10.5114/ada.2017.67842
Plewka, Danuta, et al. "Differential expression of tumor necrosis factor α, interleukin 1β, nuclear factor κB in nasal mucosa among chronic rhinosinusitis patients with and without polyps." Postepy dermatologii i alergologii vol. 34,3 (2017): 199-206. doi: https://doi.org/10.5114/ada.2017.67842
Plewka D, Grzanka A, Drzewiecka E, Plewka A, Misiołek M, Lisowska G, Rostkowska-Nadolska B, Gawlik R. Differential expression of tumor necrosis factor α, interleukin 1β, nuclear factor κB in nasal mucosa among chronic rhinosinusitis patients with and without polyps. Postepy Dermatol Alergol. 2017 Jun;34(3):199-206. doi: 10.5114/ada.2017.67842. Epub 2017 May 29. PMID: 28670247; PMCID: PMC5471375.
Copy Download .nbib Format: NLM
Long-Term Gynecological Outcomes in Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.

International journal of pediatric endocrinology

Johannsen TH, Ripa CP, Carlsen E, Starup J, Nielsen OH, Schwartz M, Drzewiecki KT, Mortensen EL, Main KM.
PMID: 20981283
Int J Pediatr Endocrinol. 2010;2010:784297. doi: 10.1155/2010/784297. Epub 2010 Oct 20.

Background. Our knowledge on long-term outcome in CAH remains incomplete. Methods. In a prospective study (33 CAH patients, 33 age-matched controls), reproductive outcomes, self-rating of genital appearance and function, and sexuality were correlated to degree of initial virilisation, genotype,...

Cite
Johannsen TH, Ripa CP, Carlsen E, et al. Long-Term Gynecological Outcomes in Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Int J Pediatr Endocrinol. 2010;2010:784297doi: 10.1155/2010/784297.
Johannsen, T. H., Ripa, C. P., Carlsen, E., Starup, J., Nielsen, O. H., Schwartz, M., Drzewiecki, K. T., Mortensen, E. L., & Main, K. M. (2010). Long-Term Gynecological Outcomes in Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. International journal of pediatric endocrinology, 2010784297. https://doi.org/10.1155/2010/784297
Johannsen, T H, et al. "Long-Term Gynecological Outcomes in Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency." International journal of pediatric endocrinology vol. 2010 (2010): 784297. doi: https://doi.org/10.1155/2010/784297
Johannsen TH, Ripa CP, Carlsen E, Starup J, Nielsen OH, Schwartz M, Drzewiecki KT, Mortensen EL, Main KM. Long-Term Gynecological Outcomes in Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Int J Pediatr Endocrinol. 2010;2010:784297. doi: 10.1155/2010/784297. Epub 2010 Oct 20. PMID: 20981283; PMCID: PMC2963122.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 34 entries